Comparing Relistor vs Symproic
Relistor (methylnaltrexone) | Symproic (naldemedine) |
|
---|
Relistor (methylnaltrexone) | Symproic (naldemedine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Opioid-Induced Constipation, Constipation - Chronic, Constipation - Drug Induced. Relistor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Opioid-Induced Constipation. Symproic may also be used for purposes not listed in this medication guide. |
Related suggestions Opioid-Induced Constipation
Popular comparisons
|
|||||||||||||||
More about Relistor (methylnaltrexone) | More about Symproic (naldemedine) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Relistor has an average rating of 6.6 out of 10 from a total of 61 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 31% reported a negative effect. |
Symproic has an average rating of 6.4 out of 10 from a total of 34 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Relistor side effects |
View all Symproic side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Relistor prices |
View all Symproic prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
8 hours |
11 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 24 drugs are known to interact with Relistor:
|
A total of 179 drugs are known to interact with Symproic:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
April 24, 2008 |
March 23, 2017 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Amitiza
Amitiza (lubiprostone) is used to treat chronic constipation and irritable bowel syndrome with ...
GoLYTELY
GoLYTELY is used for bowel preparation, constipation, chronic, gastrointestinal decontamination
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Movantik
Movantik reduces constipation caused by opioid pain medicine used to treat severe chronic pain. It ...
GaviLyte-G
GaviLyte-G is used for bowel preparation, constipation, chronic, gastrointestinal decontamination
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Suflave
Suflave is a combination, osmotic, prescription laxative that may be used to cleanse the bowel in ...
PEG-3350 with Electolytes
PEG-3350 with Electolytes is used for bowel preparation, constipation, chronic, gastrointestinal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.